Good to see cash going to all the right places. Concerning that sect 8.7 is down to 0.29. However, cash at bank would allow for some tick over so long as no further exploration (inv + op) expenses occur prior to CR $$
so long as no unexpected expenses come in prior to CR $$.
The "pending" feasibility study - will this be recorded as an operating or investing activity?
- Forums
- ASX - By Stock
- GMD
- Ann: Quarterly Cashflow Report
Ann: Quarterly Cashflow Report, page-2
Featured News
Add GMD (ASX) to my watchlist
|
|||||
Last
$2.12 |
Change
0.010(0.47%) |
Mkt cap ! $2.378B |
Open | High | Low | Value | Volume |
$2.05 | $2.15 | $2.03 | $10.14M | 4.807M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 57816 | $2.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.15 | 6996 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5461 | 2.110 |
2 | 5816 | 2.100 |
1 | 5461 | 2.090 |
1 | 5461 | 2.080 |
3 | 16470 | 2.070 |
Price($) | Vol. | No. |
---|---|---|
2.150 | 5461 | 1 |
2.160 | 5461 | 1 |
2.170 | 12600 | 3 |
2.180 | 11346 | 3 |
2.190 | 6461 | 2 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
GMD (ASX) Chart |